Modal Container (Shows only in EE)
Modal ID: #cookie-management-modal
Open Modal
Close Modal

-

PRESS RELEASE

PhRMA Japan Industry Vision Report

Japan’s rapidly aging population and recent changes to the policy environment have made reforms to the country’s health care system an urgent issue. This vision paper outlines the constructive role innovative biopharmaceutical companies can play to ensure new and innovative medicines continue to be developed and delivered to Japanese patients in a timely manner.

This patient-centric approach is supported by three key pillars: 1) Advancing innovation, 2) Securing patient access to new innovation in a sustainable universal healthcare system, and 3) Ensuring policy decisions are evidence based.

About PhRMA

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $800 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.

Connect with PhRMA

For information on how innovative medicines save lives, please visit:  
www.PhRMA.org
www.VotersforCures.org
www.MAT.org
www.Facebook.com/PhRMA 
www.X.com/PhRMA 

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.